N-benzyl-2-[(2,6-dichlorophenyl)carbamoyl-(2-methylbutyl)amino]-N-(thiophen-2-ylmethyl)acetamide
C26H29Cl2N3O2S — CID 4037489
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-benzyl-2-[(2,6-dichlorophenyl)carbamoyl-(2-methylbutyl)amino]-N-(thiophen-2-ylmethyl)acetamide
N-benzyl-2-[(2,6-dichlorophenyl)carbamoyl-(2-methylbutyl)amino]-N-(thiophen-2-ylmethyl)acetamide (PubChem CID 4037489) has the molecular formula C26H29Cl2N3O2S and a molecular weight of 518.51 g/mol. Its IUPAC name is N-benzyl-2-[(2,6-dichlorophenyl)carbamoyl-(2-methylbutyl)amino]-N-(thiophen-2-ylmethyl)acetamide.
Molecular Properties
| Compound Name | N-benzyl-2-[(2,6-dichlorophenyl)carbamoyl-(2-methylbutyl)amino]-N-(thiophen-2-ylmethyl)acetamide |
|---|---|
| PubChem CID | 4037489 |
| Molecular Formula | C26H29Cl2N3O2S |
| Molecular Weight | 518.51 g/mol |
| Exact Mass | 517.14 |
| IUPAC Name | N-benzyl-2-[(2,6-dichlorophenyl)carbamoyl-(2-methylbutyl)amino]-N-(thiophen-2-ylmethyl)acetamide |
| SMILES | CCC(C)CN(CC(=O)N(Cc1ccccc1)Cc1cccs1)C(=O)Nc1c(Cl)cccc1Cl |
| InChI | InChI=1S/C26H29Cl2N3O2S/c1-3-19(2)15-31(26(33)29-25-22(27)12-7-13-23(25)28)18-24(32)30(17-21-11-8-14-34-21)16-20-9-5-4-6-10-20/h4-14,19H,3,15-18H2,1-2H3,(H,29,33) |
| InChIKey | PWHGGZXEQNUQLD-UHFFFAOYSA-N |
| XLogP | 7.16 |
| TPSA | 52.65 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 518.51 |
| LogP ≤ 5 | 7.16 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 4037489 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.